课题基金 / 基金详情

Longitudinal Analysis of Transcriptomic Endophenotypes in Asthma

Longitudinal Analysis of Transcriptomic Endophenotypes in Asthma
哮喘转录组内表型的纵向分析
批准号:
9067839
负责人:
GEOFFREY L CHUPP
金额:
$76.9万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-15 至 2018-09-30

项目摘要

项目成果

GEOFFREY L CHUPP的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): PROJECT SUMMARY Despite differences in the underlying pathogenic mechanisms of asthma, the fundamental processes that drive lung biology are present across most, if not all, injury and repair responses. However, a major challenge is the identification of common patterns present in these conditions. Currently, asthma phenotypes have been defined in limited terms and imprecise clinical paradigms that rely on features such as allergic history, age of onset, lung function, and symptoms of "severity." These studies, including the Severe Asthma Research Program (SARP) characterization of asthma clusters, have been useful, but are driven by differences in demographic and physiologic variables, measures that are distal to many biologic aspects of the disease.4 In contrast to these approaches, integrative functional genomics has the potential to define asthma endophenotypes at a level reflective of true endophenotypes that are mechanistically important to the pathogenesis of asthma. To this end, our multidisciplinary research team has developed a molecular phenotyping protocol to evaluate transcriptomic asthma endophenotypes using genome-wide gene expression measured in the sputum and circulation of asthmatics and has identified 3 transcriptional endophenotypes of asthma (sputum TEA clusters). TEA cluster 1 has a low level of airway inflammation and the most reversible airway obstruction; TEA cluster 2 has a moderate amount of airway inflammation, reversible airflow obstruction, and high sputum IL-13 levels (Th2 cluster); and TEA cluster 3 has the highest level of airway inflammation, the least reversible airway obstruction (remodeled cluster), and high levels of sputum YKL-40 (a chitinase-like-protein we have shown to be associated with remodeling and severe asthma). In addition, using matched blood gene expression data from this cohort, we developed a predictive model using 69 genes that can determine an individual's sputum TEA cluster assignment with 85% accuracy. Taken together, these data demonstrate that transcriptomically-derived asthma endophenotypes are associated with airway inflammation, physiologic remodeling, and immunophenotype-associated cytokines. In this application, integrative functional genomics will be used to evaluate the stability of the TEA cluster model. A second independent cohort of asthma subjects will be studied longitudinally, and the innate and adaptive immune system responses associated with the TEA clusters will be determined. The generalizability of TEA clusters to other lung diseases will be evaluated to identify the fundamental expression networks associated with the TEA clusters. Ultimately, these studies will improve our understanding of asthma heterogeneity at the molecular level at the site of disease, and identify patients with similar modulation of gene networks. The results will generate new molecular diagnoses of asthma endophenotypes that can be used to sub-classify patients for pathogenetic and therapeutic studies using blood and sputum gene expression and identify novel targets for candidate gene studies.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Sputum Gene Expression of IL-13 Receptor α2 Chain Correlates with Airflow Obstruction and Helper T-Cell Type 2 Inflammation in Asthma.
IL-13 受体 α2 链的痰基因表达与哮喘中的气流阻塞和辅助 T 细胞 2 型炎症相关。
DOI: 10.1513/annalsats.201509-611mg
发表时间: 2016
期刊: Annals of the American Thoracic Society
影响因子: 8.3
作者: [Nezgovorova,Vera, Liu,Qing, Hu,Bugu, Villalobos,JoseLGomez, Yan,Xiting, Niu,Naigian, Holm,Carole, Grant,NicoleP, Marone,Sarah, Ravage-Mass,Lois, Lee,ChunGeun, Elias,JackA, Cohn,Lauren, Chupp,GeoffreyL]
通讯作者: Chupp,GeoffreyL
DOI: 10.1165/rcmb.2014-0049oc
发表时间: 2014-10
期刊: American journal of respiratory cell and molecular biology
影响因子: 6.4
作者: [T. Shibata;U. Ismailoglu;N. Kittan;A. Moreira;A. Coelho;G. Chupp;S. Kunkel;N. Lukacs;C. Hogaboam]
通讯作者: T. Shibata;U. Ismailoglu;N. Kittan;A. Moreira;A. Coelho;G. Chupp;S. Kunkel;N. Lukacs;C. Hogaboam
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma
  • 批准号:
    9144910
  • 项目类别:
  • 资助金额:
    $125.81万
  • 财政年份:
    2014
  • 负责人:
    GEOFFREY L CHUPP
  • 依托单位:
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma
  • 批准号:
    8931050
  • 项目类别:
  • 资助金额:
    $162.37万
  • 财政年份:
    2014
  • 负责人:
    GEOFFREY L CHUPP
  • 依托单位:
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma
  • 批准号:
    8758113
  • 项目类别:
  • 资助金额:
    $166.32万
  • 财政年份:
    2014
  • 负责人:
    GEOFFREY L CHUPP
  • 依托单位:
Pre-Clinical Development of a Novel Anti-YKL-40 Biologic to Treat Severe Asthma
  • 批准号:
    9340261
  • 项目类别:
  • 资助金额:
    $164.59万
  • 财政年份:
    2014
  • 负责人:
    GEOFFREY L CHUPP
  • 依托单位:
海外基金